8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT02509546 · COMPLETED

Trial details

NCT number: NCT02509546
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia

Start date: 2015-09-02
Primary completion: 2021-03-09
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.